Skip to main content

Find Clinical Trials

Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,001 public trials 2,038 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Effectiveness of Lay Navigators in Meeting Cancer Patients' Non-Clinical Needs: A Pilot Study

NCT03245788

Conditions: Bone Marrow Transplant, Breast Cancer, Breast Diseases, +35 more
Locations: Stanford Cancer Center Palo Alto, California, United States

View Trial Details

Completed

Carfilzomib, Pegylated Liposomal Doxorubicin Hydrochloride, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

NCT01246063

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Completed

Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation

NCT02930850

Conditions: Anemia, Healthy, Hematologic Diseases, +11 more
Locations: Site 4 Burbank, California, United States

Site 5 Burbank, California, United States

Site 2 Irvine, California, United States

Site 7 Lake Forest, California, United States

View Trial Details

Completed

The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis

NCT02632786

Conditions: AL Amyloidosis, Alzheimer Disease, Amyloidosis, +22 more
Locations: City of Hope Duarte, California, United States

Stanford Cancer Institute (SCI) Stanford, California, United States

Colorado Blood Cancer Institute Denver, Colorado, United States

Mayo Clinic Jacksonville, Florida, United States

View all 40 locations

View Trial Details

Completed

A Phase I, Multicenter Dose Escalation Study in Patients With Hairy Cell Leukemia

NCT00586924

Conditions: Hairy Cell Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations: Research Site Stanford, California, United States

Research Site Chicago, Illinois, United States

Research Site Bethesda, Maryland, United States

Research Site Lodz, Poland

View Trial Details

Completed

Lipoprotein Lipase Expression in Chronic Lymphocytic Leukemia

NCT01460238

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States

View Trial Details

Completed

Eicosanoid Lipids by Airway Cells During Infection With Human Rhinoviruses

NCT01898767

Conditions: Asthma, Bronchial Diseases, Hemic and Lymphatic Diseases, +15 more
Locations: UW Madison Madison, Wisconsin, United States

View Trial Details

Completed

Autologous and Allogeneic Transplant for Relapsed Lymphoma

NCT00802113

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkins Disease, +9 more
Locations: Children's Memorial Hospital in Chicago Chicago, Illinois, United States

Hackensack University Medical Center Hackensack, New Jersey, United States

Columbia University Medical Center New York, United States

New York Medical College Valhalla, New York, United States

View Trial Details

Completed

Belinostat for Solid Tumors and Lymphomas in Patients With Varying Degrees of Hepatic Dysfunction

NCT01273155

Conditions: Digestive System Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: University of California, Davis Davis, California, United States

City of Hope National Medical Center Duarte, California, United States

USC Norris Cancer Center Los Angeles, California, United States

Emory University Atlanta, Georgia, United States

View Trial Details

Completed

A Phase I/IIa Open-Label, Dose Escalation and Cohort Expansion Trial of Oral TSR-011 in Patients With Advanced Solid Tumors and Lymphomas

NCT02048488

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +16 more
Locations: Goodyear, Arizona, United States

Scottsdale, Arizona, United States

Los Angeles, California, United States

Nashville, Tennessee, United States

View all 15 locations

View Trial Details